These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36300278)

  • 1. The adenosine A
    Franco R; Lillo A; Navarro G; Reyes-Resina I
    Expert Opin Ther Targets; 2022 Sep; 26(9):791-800. PubMed ID: 36300278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the adenosine A
    Zhao Y; Zhou YG; Chen JF
    Chin J Traumatol; 2024 May; 27(3):125-133. PubMed ID: 37679245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting adenosine A
    Congreve M; Brown GA; Borodovsky A; Lamb ML
    Expert Opin Drug Discov; 2018 Nov; 13(11):997-1003. PubMed ID: 30336706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic relevance of adenosine A2B and A2A receptors in the central nervous system.
    Popoli P; Pepponi R
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):664-74. PubMed ID: 22963436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A
    Lambertucci C; Marucci G; Catarzi D; Colotta V; Francucci B; Spinaci A; Varano F; Volpini R
    Curr Med Chem; 2022 Aug; 29(28):4780-4795. PubMed ID: 35184706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A
    Yu F; Zhu C; Xie Q; Wang Y
    J Med Chem; 2020 Nov; 63(21):12196-12212. PubMed ID: 32667814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
    Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
    Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A
    Franco R; Rivas-Santisteban R; Casanovas M; Lillo A; Saura CA; Navarro G
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A
    Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
    J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8
    Yu F; Zhu C; Ze S; Wang H; Yang X; Liu M; Xie Q; Lu W; Wang Y
    J Med Chem; 2022 Mar; 65(5):4367-4386. PubMed ID: 35212542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
    Cacciari B; Spalluto G; Federico S
    Mini Rev Med Chem; 2018; 18(14):1168-1174. PubMed ID: 29692248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
    Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
    Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blocking Adenosine/A2AR Pathway for Cancer Therapy].
    Liu J; Shi Y; Liu X; Zhang D; Bai Y; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):460-467. PubMed ID: 35899442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Substituted 2-benzylidene-1-tetralone analogues as A
    Janse van Rensburg HD; Terre'Blanche G; van der Walt MM; Legoabe LJ
    Bioorg Chem; 2017 Oct; 74():251-259. PubMed ID: 28881253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The belated US FDA approval of the adenosine A
    Chen JF; Cunha RA
    Purinergic Signal; 2020 Jun; 16(2):167-174. PubMed ID: 32236790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A
    Zhu C; Ze S; Zhou R; Yang X; Wang H; Chai X; Fang M; Liu M; Wang Y; Lu W; Xie Q
    J Med Chem; 2023 Apr; 66(7):4734-4754. PubMed ID: 36951370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.